Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinities

被引:7
作者
Lundquist, JT
Büllesbach, EE
Dix, TA
机构
[1] Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA
关键词
D O I
10.1016/S0960-894X(00)00018-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Recent evidence is consistent with neurotensin (NT)(8-13) adopting a Type I beta-turn conformation while binding the NT receptor, which would place the cationic side-chains of Arg(8) and Arg(9) in close proximity. This was the basis for the design, synthesis and analysis of truncated NT(9-13) analogues 1-5 with dicationic position 9 side-chains to emulate the functions of the 8 and 9 side-chains of NT(8-13). (C) 2000 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:453 / 455
页数:3
相关论文
共 18 条
[11]   Asymmetric synthesis of ω-bromo-2(S)-azido acids as precursors for the synthesis of novel amino acids [J].
Lundquist, JT ;
Dix, TA .
TETRAHEDRON LETTERS, 1998, 39 (08) :775-778
[12]  
MARCH J, 1985, ADV ORGANIC CHEM REA, P364
[13]  
MEIENHOFER J, 1979, INT J PEPT PROT RES, V13, P3
[14]   Proposed ligand binding site of the transmembrane receptor for neurotensin(8-13) [J].
Pang, YP ;
Cusack, B ;
Groshan, K ;
Richelson, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (25) :15060-15068
[15]  
Pardridge W. M., 1991, PEPTIDE DRUG DELIVER, P123
[16]  
STEIN WD, 1967, MOVEMENT MOLECULES A, P72
[17]  
VONEULER G, 1991, J NEUROCHEM, V56, P178
[18]  
WIDERLOV E, 1982, AM J PSYCHIAT, V139, P1122